Related Experiment Video
Updated: Nov 7, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Differences in D-dimer blood concentration in atrial fibrillation patients with left atrial thrombus or severe left
Changjian Lin1, Yangyang Bao1, Wei Hua1
1Department of Cardiology, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijin Er Road, Shanghai, 200025, China.
Insights
In atrial fibrillation (AF) patients, lower D-dimer levels in severe left atrial spontaneous echo contrast (SLASEC) indicate a lower risk of left atrial thrombus (LAT) compared to those with LAT. D-dimer may predict LAT thrombolysis.
Area of Science:
- Cardiology
- Hematology
- Diagnostic Imaging
Background:
- Severe left atrial spontaneous echo contrast (SLASEC) is a precursor to left atrial thrombus (LAT) and a risk factor for thromboembolic events.
- The role of D-dimer in excluding LAT in atrial fibrillation (AF) patients is suggested, but differences between SLASEC and LAT D-dimer levels are unclear.
Purpose of the Study:
- To investigate whether D-dimer blood concentrations differ between AF patients with SLASEC and those with LAT.
- To evaluate D-dimer as a potential marker for distinguishing pre-thrombotic states from established thrombi.
Main Methods:
- Prospective study of nonvalvular AF patients undergoing TEE for SLASEC or LAT detection.
- D-dimer concentrations and CHA2DS2-VASc scores were measured and evaluated.
- Follow-up for thromboembolic complications in the SLASEC group.
Main Results:
- AF patients with SLASEC had significantly lower D-dimer levels (0.26±0.13 mg/L) and CHA2DS2-VASc scores (2.3±0.9) compared to those with LAT (D-dimer: 0.86±0.9 mg/L, P<0.05; CHA2DS2-VASc: 3.1±1.5, P=0.02).
- A D-dimer cut-off of 0.285 mg/L showed 77.3% sensitivity and 80.0% specificity for predicting LAT.
- D-dimer levels decreased significantly after anticoagulation treatment in patients with resolved LAT (0.42±0.22 vs. 0.33±0.18 mg/L, P=0.03).
- No thromboembolic events occurred in the SLASEC group during follow-up.
Conclusions:
- Lower D-dimer concentrations and CHA2DS2-VASc scores are associated with SLASEC compared to LAT in AF patients.
- A D-dimer cut-off of 0.285 mg/L can help differentiate between pre-thrombotic states and LAT.
- D-dimer may serve as a predictive marker for LAT resolution through anticoagulation.
Purpose:
Severe left atrial spontaneous echo contrast (SLASEC) is considered the prior stage to thrombosis and a high-risk factor for thrombotic events. Studies have suggested an effect of D-dimer blood concentration on exclusion of left atrial thrombus (LAT), but it remains unclear whether D-dimer concentrations differ between atrial fibrillation (AF) patients with SLASEC or LAT.
Methods:
Nonvalvular AF patients scheduled to undergo catheter ablation or cardioversion in Shanghai Ruijin Hospital between January 2017 and July 2020 were screened for this prospective study. All patients underwent transesophageal echocardiography (TEE) to detect SLASEC or LAT. D-dimer concentrations were measured at the time of TEE. Clinical data including CHA2DS2-VASc score were evaluated. Major complications with thromboembolism in the SLASEC group were followed up at least 6 months after therapy.
Results:
Among 920 consecutively enrolled nonvalvular AF patients, 30 patients with SEC grade 0, 35 patients with SLASEC, and 22 patients with LAT were included. D-dimer concentration and CHA2DS2-VASc score were significantly lower in the SLASEC group compared with the LAT group (D-dimer, 0.26±0.13 vs. 0.86±0.9 mg/L, P<0.05; CHA2DS2-VASc score, 2.3±0.9 vs. 3.1±1.5, P=0.02). The cut-off value for D-dimer concentration (0.285 mg/L) had sensitivity of 77.3% and specificity of 80.0% for prediction of LAT. D-dimer concentration showed a decreasing trend with a significant difference (0.42±0.22 vs. 0.33±0.18 mg/L, P=0.03) for 9 patients in the LAT group after complete thrombus resolution by anticoagulation treatment. No major or fatal bleeding, ischemic stroke, or systemic thromboembolism events occurred in the SLASEC group during the 6-month follow-up.
Conclusions:
This study demonstrated a significantly lower D-dimer concentration and CHA2DS2-VASc score in AF patients with SLASEC than in those with LAT. The D-dimer cut-off value (0.285 mg/L) can be used as an effective reference index to distinguish the pre-thrombotic state of LAT from LAT. D-dimer blood concentration may be a predictor of LAT thrombolysis.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

